Publications by authors named "Miah Jung"

Claim this Profile
A
An FDA Analysis of Inspected Entities After Receiving Official Action Indicated Letters for Good Clinical Practice Violations.
Miah Jung, Rachelle M Swann, Michelle S Anantha, Faranak Jamali

Ther Innov Regul Sci· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective SPECT-CT Organ Dosimetry-Driven Radiation-Absorbed Dose Escalation Using the In-111 (In)/Yttrium 90 (Y) Ibritumomab Tiuxetan (Zevalin) Theranostic Pair in Patients with Lymphoma at Myeloablative Dose Levels.
Richard L Wahl, Eric C Frey, Heather A Jacene, Brad S Kahl, Steven Piantadosi, Miah Jung

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Social networks in cardiovascular disease management.
Fadia T Shaya, Xia Yan, Maryam Farshid, Samer Barakat, Miah Jung

Expert Rev Pharmacoecon Outcomes Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost effectiveness and budget impact of natalizumab for formulary inclusion.
Justin Bakhshai, Raymond Bleu-Lainé, Miah Jung, Jeanne Lim, Christian Reyes

J Med Econ· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case for a pharmacy-centered medical home.
Fadia T Shaya, Sara Low, Sameh Barakat, Maryam Farshid, Miah Jung

Expert Rev Pharmacoecon Outcomes Res· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis